Search Results 111-120 of 17274 for egfr

  1. Publications - Yanyan Lou, M.D., Ph.D. - Mayo Clinic

    Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer. Front Oncol. 2021; 11:751209 Epub 2021 Nov 16. View PubMed ...

  2. A Study of Afatinib Treatment for Patients with Epidermal Growth Factor Receptor Mutation Positive Non-Small Cell Lung Cancer, Who Are Age 70 or Older - Mayo Clinic

    ... EGFR (epidermal growth factor receptor) mutations. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and ...

  3. A Study Of Radiation Dosimetry, Safety, And Tolerability Of Extended Lutetium (177Lu) Vipivotide Tetraxetan Treatment In Chemo-naïve Adults With Metastatic Castration-resistant Prostate Cancer

    ... (eGFR ≥ 60ml/min). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health ...

  4. Health disparities in preventive screenings for African Americans - Mayo Clinic News Network

    Historically, the formulas include a Black race variable which increased eGFR values for this population and overestimated kidney function by up to 16%. This ...

  5. Publications - Hussam Al Kateb, Ph.D. - Mayo Clinic

    EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype? J Neuropathol Exp Neurol. 2025 Nov 1; 84 (11):1059-1062. View PubMed ...

  6. Publications - Jorge A. Trejo-Lopez, M.D. - Mayo Clinic

    EGFR transcript variants: Potential diagnostic biomarker for glioblastoma, IDH-wildtype? J Neuropathol Exp Neurol. 2025 Nov 1; 84 (11):1059-1062. View PubMed ...

  7. Publications - Kah Whye Peng, Ph.D. - Mayo Clinic

    Jiang H, Nace R, Ferguson C, Zhang L, Peng KW, Russell SJ. Oncolytic cytomegaloviruses expressing EGFR-retargeted fusogenic glycoprotein complex and drug- ...

  8. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and progression of ...

  9. Uncovering the Signaling Events Underlying the Development and Progression of Pancreatic Cancer - Tumor Development, Immunology and Progression Laboratory - Mayo Clinic Research

    ... (EGFR). Dr. Storz and his research team hope to determine the roles of KRas- and NF-κB-induced signaling pathways in the development and progression of ...

  10. Carcinoma Clinical Trials - Mayo Clinic Research

    Ficerafusp alfa is directed against two targets, Epidermal Growth Factor Receptor (EGFR) and Transforming Growth Factor beta (TGF-β). This study intends to ...